James A Platts-Mills1, Margaret Kosek. 1. aDivision of Infectious Diseases and International Health, University of Virginia Health System, Charlottesville, Virginia bDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Recent work has added to the understanding of the burden of Campylobacter jejuni, C. coli, and non-jejuni/coli Campylobacter strains in children living in the developing world. RECENT FINDINGS: New diagnostic modalities and carefully designed field studies are demonstrating that the burden of Campylobacter diarrhea in children in the developing world has been greatly underestimated. Furthermore, there is emerging recognition of an association between Campylobacter infection and malnutrition. Important progress has been made toward a Campylobacter jejuni vaccine. Finally, evidence of antibiotic resistance continues to be an important issue that is accentuated by the realization that the burden of disease is greater than previously recognized. SUMMARY: Additional research is needed to refine our understanding of the epidemiology of Campylobacter infections in developing countries, in particular to improve estimates of the burden of Campylobacter diarrhea in endemic settings, to determine the impact of recurrent Campylobacter infections on child development, and to describe the prevalence and clinical significance of non-jejuni/coli Campylobacter infections. Progressive antibiotic resistance of isolates argues for augmented and expanded control measures of antibiotics in livestock. Continued work in vaccine development is warranted as is the extension of data available on the serotypes related to burden in different areas of the world and the relationship of serotypes to disease severity.
PURPOSE OF REVIEW: Recent work has added to the understanding of the burden of Campylobacter jejuni, C. coli, and non-jejuni/coli Campylobacter strains in children living in the developing world. RECENT FINDINGS: New diagnostic modalities and carefully designed field studies are demonstrating that the burden of Campylobacterdiarrhea in children in the developing world has been greatly underestimated. Furthermore, there is emerging recognition of an association between Campylobacterinfection and malnutrition. Important progress has been made toward a Campylobacter jejuni vaccine. Finally, evidence of antibiotic resistance continues to be an important issue that is accentuated by the realization that the burden of disease is greater than previously recognized. SUMMARY: Additional research is needed to refine our understanding of the epidemiology of Campylobacterinfections in developing countries, in particular to improve estimates of the burden of Campylobacterdiarrhea in endemic settings, to determine the impact of recurrent Campylobacterinfections on child development, and to describe the prevalence and clinical significance of non-jejuni/coli Campylobacterinfections. Progressive antibiotic resistance of isolates argues for augmented and expanded control measures of antibiotics in livestock. Continued work in vaccine development is warranted as is the extension of data available on the serotypes related to burden in different areas of the world and the relationship of serotypes to disease severity.
Authors: James A Platts-Mills; Jie Liu; Jean Gratz; Esto Mduma; Caroline Amour; Ndealilia Swai; Mami Taniuchi; Sharmin Begum; Pablo Peñataro Yori; Drake H Tilley; Gwenyth Lee; Zeli Shen; Mark T Whary; James G Fox; Monica McGrath; Margaret Kosek; Rashidul Haque; Eric R Houpt Journal: J Clin Microbiol Date: 2014-01-22 Impact factor: 5.948
Authors: Jaap A Wagenaar; Marcel A P van Bergen; Martin J Blaser; Robert V Tauxe; Diane G Newell; Jos P M van Putten Journal: Clin Infect Dis Date: 2014-02-18 Impact factor: 9.079
Authors: Richard F de Boer; Alewijn Ott; Pinar Güren; Evert van Zanten; Alex van Belkum; Anna M D Kooistra-Smid Journal: J Clin Microbiol Date: 2012-11-14 Impact factor: 5.948
Authors: Wycliffe Omurwa Masanta; Markus M Heimesaat; Stefan Bereswill; Abdul Malik Tareen; Raimond Lugert; Uwe Groß; Andreas E Zautner Journal: Clin Dev Immunol Date: 2013-11-14
Authors: Renee M Laird; Zuchao Ma; Nelum Dorabawila; Brittany Pequegnat; Eman Omari; Yang Liu; Alexander C Maue; Steven T Poole; Milton Maciel; Kavyashree Satish; Christina L Gariepy; Nina M Schumack; Annette L McVeigh; Frédéric Poly; Cheryl P Ewing; Michael G Prouty; Mario A Monteiro; Stephen J Savarino; Patricia Guerry Journal: Vaccine Date: 2018-09-27 Impact factor: 3.641
Authors: Jeticia R Sistrunk; Kourtney P Nickerson; Rachael B Chanin; David A Rasko; Christina S Faherty Journal: Clin Microbiol Rev Date: 2016-10 Impact factor: 26.132
Authors: Steev Loyola; Juan F Sanchez; Edson Maguiña; Enrique Canal; Rosa Castillo; Manuela Bernal; Yocelinda Meza; Drake H Tilley; William E Oswald; Kristen Heitzinger; Andres G Lescano; Claudio A Rocha Journal: Am J Trop Med Hyg Date: 2020-06 Impact factor: 2.345